Orion Pharma (UK) Limited

Oaklea Court, 22 Park Street, Newbury, Berkshire, RG14 1EA
Telephone: +44 (0)1635 520 300
Fax: +44 (0)1635 580 180
Medical Information e-mail: medicalinformation@orionpharma.com
Out of Hours Telephone: +44 (0)1635 520 300

Patient Information Leaflet last updated on the eMC: 07/02/2012
PIL Kentera oxybutynin transdermal patch

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 27/09/2011 and displayed until 07/02/2012
Reasons for adding or updating:
  • Unknown
Updated on 15/10/2010 and displayed until 27/09/2011
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 19/07/2010 and displayed until 15/10/2010
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 14/11/2008 and displayed until 19/07/2010
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   oxybutynin